Entering text into the input field will update the search result below

Dr. Reddy's launches generic Angiomax in U.S.

Jun. 06, 2017 7:25 AM ETDr. Reddy's Laboratories Limited (RDY) StockBy: Douglas W. House, SA News Editor
  • Dr. Reddy's Laboratories (NYSE:RDY) commences the U.S. commercial launch of its generic version of The Medicines Company's (MDCO) anticoagulant Angiomax (bivalirudin).
  • According to IMS Health, the U.S. market is ~$200M.

Recommended For You

More Trending News

About RDY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RDY--
Dr. Reddy's Laboratories Limited